Novo Nordisk A/S (NEO:NVON)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of CAD 282.40 billion. The enterprise value is 297.37 billion.

Market Cap	282.40B
Enterprise Value	297.37B

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.46%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	29.45%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 12.44 and the forward PE ratio is 11.65.

PE Ratio	12.44
Forward PE	11.65
PS Ratio	4.09
PB Ratio	7.60
P/TBV Ratio	20.38
P/FCF Ratio	19.56
P/OCF Ratio	10.43
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.41, with an EV/FCF ratio of 20.60.

EV / Earnings	13.10
EV / Sales	4.32
EV / EBITDA	8.41
EV / EBIT	9.17
EV / FCF	20.60

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.60.

Current Ratio	0.78
Quick Ratio	0.53
Debt / Equity	0.60
Debt / EBITDA	0.62
Debt / FCF	1.53
Interest Coverage	18.58

Financial Efficiency

Return on equity (ROE) is 71.46% and return on invested capital (ROIC) is 41.42%.

Return on Equity (ROE)	71.46%
Return on Assets (ROA)	20.43%
Return on Invested Capital (ROIC)	41.42%
Return on Capital Employed (ROCE)	53.49%
Revenue Per Employee	898,915
Profits Per Employee	295,571
Employee Count	77,349
Asset Turnover	0.69
Inventory Turnover	1.30

Taxes

In the past 12 months, Novo Nordisk has paid 6.16 billion in taxes.

Income Tax	6.16B
Effective Tax Rate	21.33%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5.81
200-Day Moving Average	n/a
Relative Strength Index (RSI)	21.98
Average Volume (20 Days)	93,614

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of CAD 69.06 billion and earned 22.71 billion in profits. Earnings per share was 5.11.

Revenue	69.06B
Gross Profit	56.87B
Operating Income	32.53B
Pretax Income	28.86B
Net Income	22.71B
EBITDA	35.12B
EBIT	32.53B
Earnings Per Share (EPS)	5.11

Balance Sheet

The company has 7.13 billion in cash and 22.15 billion in debt, giving a net cash position of -15.02 billion.

Cash & Cash Equivalents	7.13B
Total Debt	22.15B
Net Cash	-15.02B
Net Cash Per Share	n/a
Equity (Book Value)	37.18B
Book Value Per Share	8.37
Working Capital	-11.48B

Cash Flow

In the last 12 months, operating cash flow was 27.09 billion and capital expenditures -12.65 billion, giving a free cash flow of 14.44 billion.

Operating Cash Flow	27.09B
Capital Expenditures	-12.65B
Free Cash Flow	14.44B
FCF Per Share	n/a

Margins

Gross margin is 82.35%, with operating and profit margins of 47.10% and 32.88%.

Gross Margin	82.35%
Operating Margin	47.10%
Pretax Margin	41.80%
Profit Margin	32.88%
EBITDA Margin	50.85%
EBIT Margin	47.10%
FCF Margin	20.90%

Dividends & Yields

Novo Nordisk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	49.88%
Buyback Yield	0.46%
Shareholder Yield	0.46%
Earnings Yield	8.04%
FCF Yield	5.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 6.13 and a Piotroski F-Score of 4.

Altman Z-Score	6.13
Piotroski F-Score	4